Pathophysiology of diabetic dyslipidemia:implications for atherogenesis and treatment
Authors:
- 1 August 2011
- journal article
- Published by Taylor & Francis in Clinical Lipidology
- Vol. 6 (4) , 401-411
Abstract
No abstract availableThis publication has 76 references indexed in Scilit:
- Metabolic syndrome predicts vascular changes in whole body magnetic resonance imaging in patients with long standing diabetes mellitusCardiovascular Diabetology, 2010
- Effects of Combination Lipid Therapy in Type 2 Diabetes MellitusNew England Journal of Medicine, 2010
- Harmonizing the Metabolic SyndromeCirculation, 2009
- Reversal of Small, Dense LDL Subclass Phenotype by Normalization of AdiposityObesity, 2009
- Rosuvastatin 20 mg restores normal HDL-apoA-I kinetics in type 2 diabetesJournal of Lipid Research, 2009
- Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 DiabetesNew England Journal of Medicine, 2008
- Effects of Intensive Glucose Lowering in Type 2 DiabetesNew England Journal of Medicine, 2008
- Effect of a Multifactorial Intervention on Mortality in Type 2 DiabetesNew England Journal of Medicine, 2008
- Efficacy of cholesterol-lowering therapy in 18 686 people with diabetes in 14 randomised trials of statins: a meta-analysisThe Lancet, 2008
- Nonfasting Triglycerides and Risk of Myocardial Infarction, Ischemic Heart Disease, and Death in Men and WomenJAMA, 2007